title: A case report of bevacizumab-related osteonecrosis of the jaw: old problem, new culprit.
authors.forename: Umut
authors.initials: U
authors.lastname: Dişel
authors.forename: Ali Ayberk
authors.initials: AA
authors.lastname: Beşen
authors.forename: Özgür
authors.initials: Ö
authors.lastname: Özyılkan
authors.forename: Efsun
authors.initials: E
authors.lastname: Er
authors.forename: Tuba
authors.initials: T
authors.lastname: Canpolat
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000068258:Bevacizumab; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D008297:Male; D008875:Middle Aged; D010020:Osteonecrosis / Q000139:chemically induced* / Q000000981:diagnostic imaging; D011859:Radiography; D012811:Sigmoid Neoplasms / Q000188:drug therapy / Q000556:secondary
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab